GlassScriptPhysician profile
Bret T Henderson
NPI 1659500049
$2,978.45
in general payments reported to CMS, 2019-2025
36 companies · $875 in 2025
The $875 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $257 · 2021: $377 · 2022: $320 · 2023: $394 · 2024: $401 · 2025: $875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,670.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $490.53 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $323.13 | 2019-2025 | |
| Abbvie INC. | $265.22 | 2020-2023 | |
| Sumitomo Pharma America, INC. | $195.33 | 2023-2025 | Myfembree |
| Duchesnay USA Incorporated | $193.89 | 2019 | |
| Hologic Sales and Service, LLC | $186.63 | 2019-2025 | Aptima |
| Pfizer INC. | $136.52 | 2019-2025 | |
| Coopersurgical, INC. | $122.48 | 2022-2025 | Advincula Delineator Uterine Manipulator, Ally II Ups |
| Sage Therapeutics, LLC | $118.58 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $116.67 | 2023-2025 | Veozah |
| Biogen, INC. | $113.47 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $81.53 | 2019-2022 | |
| Samsung Hme America, INC. | $58.68 | 2022 | |
| Exeltis, USA INC. | $50.44 | 2019-2023 | Slynd |
| Avion Pharmaceuticals | $45.33 | 2020-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $40.96 | 2024-2025 | |
| Myovant Sciences INC. | $40.72 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.11 | 2020 | |
| Shield Therapeutics INC | $35.60 | 2024-2025 | |
| Millicent US INC | $32.44 | 2024 | Femring, Intrarosa |
| Aspira Women'S Health INC | $31.35 | 2021 | |
| Organon LLC | $28.90 | 2023-2024 | Nexplanon |
| Agile Therapeutics, INC. | $28.73 | 2021-2022 | |
| Smith+Nephew, INC. | $24.18 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $21.35 | 2023 | Vivjoa |
| Exact Sciences Corporation | $19.69 | 2025 | The Cologuard Plus Collection Kit |
| Coloplast Corp | $19.25 | 2021 | |
| Daiichi Sankyo INC. | $17.64 | 2019 | |
| Meditrina | $15.24 | 2023 | |
| Currax Pharmaceuticals LLC | $14.48 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.45 | 2021 | |
| Mission Pharmacal Company | $12.89 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.68 | 2019 | |
| Merck Sharp & Dohme LLC | $11.75 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.12 | 2021 | |
| Heraeus Medical, LLC. | $8.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.